Lung cancer is one of the most common solid tumors worldwide and the leading cause of
cancer-related deaths, causing a devastating impact on human health. The clinical …

Small cell lung cancer (SCLC), a smoking-related highly aggressive neuroendocrine cancer,
is characterized by rapid cell proliferation, early metastatic dissemination, and early relapse …

Background This study aimed to investigate the prognostic value of baseline hemoglobin‐to‐
red blood cell distribution width ratio (HRR) in patients with small cell lung cancer (SCLC) …

Lung cancer is considered one of the most fatal malignant neoplasms because of its late
detection. Detecting molecular markers in samples from routine bronchoscopy, including …

The prognosis of neuroendocrine neoplasms (NENs) is widely variable and has been
shown to associate with several tissue-and blood-based biomarkers in different settings. The …

Neuroendocrine neoplasms (NEN) are infrequent malignant tumors of a neuroendocrine
nature that arise in various organs. They occur most frequently in the lungs, intestines …

Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer,
accounting for about 85% of all cases. MicroRNAs are stable molecules in the blood and …

Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies, with a variable
prognosis and behavior, that to date have been mainly defined by tissuebased …

Abstract MicroRNA-205 (miR-205) was revealed as a novel diagnostic and prognostic
biomarker for lung cancer, but the results in the published papers were inconsistent. This …

Background Small‐cell lung cancer (SCLC) is one of the most aggressive cancers with
mechanisms far from understood. Objective We proposed to identify valuable prognostic …